COVID-19: Reasons to discourage off-label drug treatmentsRandomized controlled trials are the only way to find effective and safe treatments for COVID-19 Care in the time of CoronaThe quiet sea doesn’t make us good sailers, waves and storms will do. Health Canada temporary exemption gives pharmacists more controlled substance authority Until September 30, pharmacists have authority to adapt, adjust and renew prescriptions for controlled substances, using their professional judgment CPhM releases community pharmacy safety culture toolkit Reminder to update patient profiles in hospital settings PTCB launches programs for techs in advanced roles; funds naloxone training Mental health assistance program for Ontario techs B.C. techs must complete OAT-CAMPP training New Canadian guideline on low-dose ASA for prevention of vascular events ASA no longer recommended for primary prevention in individuals without a history of symptomatic cardiovascular disease, stroke or peripheral artery disease Tech refresher: Showing sensitivity to LGBTQ patients Patients should not take Aspirin to prevent first stroke, heart disease: new guidelines The new recommendations only apply to those who have not had a stroke, heart condition or peripheral artery disease Hydroxychloroquine for COVID-19 prevention or treatment lacks clinical evidence Pharmacy and medical organizations issue statements to discourage off-label prescribing First Previous 357 358 359 360 361 Next Last
